BORTEZOMIB TEVA 1 MG

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Toimeaine:

BORTEZOMIB

Saadav alates:

ABIC MARKETING LTD, ISRAEL

ATC kood:

L01XX32

Ravimvorm:

POWDER FOR SOLUTION FOR INJECTION

Koostis:

BORTEZOMIB 1 MG

Manustamisviis:

I.V

Retsepti tüüp:

Required

Valmistatud:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Terapeutiline ala:

BORTEZOMIB

Näidustused:

Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

Loa andmise kuupäev:

2017-07-04